Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Genmedica Therapeutics

Request full access

Barcelona-based development-stage biotechnology company focused on type 2 diabetes

Barcelona, SpainFounded 2004Biotech & Life Sciences

About Genmedica Therapeutics

Genmedica Therapeutics, established in Barcelona, Spain in 2004, operated as a biotechnology firm focused on developing treatments for type 2 diabetes. The company was co-founded by Antonio Zorzano, a researcher and coordinator of the Molecular Medicine Programme at IRB Barcelona. This connection highlights the company's foundation in robust scientific research.

The core of Genmedica's strategy was its proprietary OSIF platform, engineered to create dual-action, small molecule therapeutics. These molecules were designed to combat both oxidative stress and inflammation, two key factors in metabolic diseases. The business model centered on the discovery and progression of these proprietary chemical entities through the drug development pipeline, with the ultimate goal of offering improved therapeutic options to diabetic patients.

Throughout its operational history, the company successfully raised approximately $20.9 million over four funding rounds, attracting institutional investors such as Asclepios Bioresearch, Ferrer, and Caixa Capital Risc. A significant milestone was a €12 million Series B investment in 2012 from Asclepios Bioresearch, intended to fund the advancement of a diabetes drug into clinical trials. The company's lead candidate reached phase II trials, and it had two other candidates in early-stage testing for diabetes and obesity. Despite these developments, Genmedica Therapeutics is now considered a deadpooled company.

Source: Dealroom company data

At a glance

Status
Operational
Open positions
None listed
Dealroom signal
54.2/100
Industry
Health
Sub-industry
BioTechnology
Sector
Personal Health, Diabetes, Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
Client focus
B2B

Funding history

4 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
EARLY VCEquity / VC Dec 2015 $1.9M $7.5M Undisclosed —
EARLY VCEquity / VC Feb 2014 $1.1M $4.4M Undisclosed —
Showing the latest 2 of 4 recorded eventsBook a demo for the full funding history →

Growth signals

Genmedica Therapeutics website traffic

Latest recorded traffic for Genmedica Therapeutics is 90 monthly website visits.

Latest monthly visits90
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Genmedica Therapeutics in the Barcelona ecosystem

Live from Dealroom

The Genmedica Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

2 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A2 investors entered at this stage

Team profiled 3 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇪🇸 Spain · Barcelona HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Genmedica Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Genmedica Therapeutics’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.